SBIO (ALPS Medical Breakthroughs ETF) Stock Analysis - AI Report

ALPS Medical Breakthroughs ETF (SBIO) is a publicly traded the market company. As of May 21, 2026, SBIO trades at $58.43 with a market cap of $0 and a P/E ratio of 0.00. SBIO moved +0.00% today. Year to date, SBIO is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces SBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What is the AI research view on SBIO?

Rallies AI research for SBIO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.

SBIO Key Metrics

Key financial metrics for SBIO
MetricValue
Price$58.43
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume114.58K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

SBIO Analyst Consensus

SBIO analyst coverage data. Average price target: $0.00.

Common questions about SBIO

What is the AI research view on SBIO?
Rallies AI research for SBIO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for SBIO?
Rallies AI research for SBIO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is SBIO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SBIO. It does not provide personalized investment advice.
SBIO

SBIO